florbetaben f-18 · Lantheus · NDA 204677
Neuraceq
Earliest generic entry, as listed
14 Jul 2032
Blocked by patent: US 9308284.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9308284 | product | 14 Jul 2032 |
| US 7807135 | substance, product, use U-1497 | 18 Mar 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 204677 · 001 · RLD | solution, intravenous | 1.4-135mCi/ML | 14 Jul 2032 |